Tag: #lifesciences

Blog is guest authored by Harry Clifford from NVIDIA. To help customers easily build, deploy, and scale workloads, Amazon Omics now supports pre-built Ready2Run workflows from third-party software companies and open-source pipelines. Read more about the launch here. As the cost of sequencing a human genome continues to decrease, the volume of sequencing data is […]

The AWS Life Sciences Team is excited about the upcoming Bio-IT World Conference and Expo 2023 in Boston from May 16-18. The symposium unites a community of life sciences and technology experts from around the world, and is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive […]

Blog is guest authored by Guy Vinograd, Co-founder and Chief Technology Officer at BioT. With a vision to make world-class medical care accessible to patients wherever they are, Israeli startup BioT provides a platform for building cloud-powered medical devices. Its innovative technology helps connect Internet of Things (IoT) medical devices to the cloud. This allows […]

Data is at the heart of any modern pharmaceutical company throughout every stage of the value chain. Understandably, data is also central to industry regulations and continues to be one of the main topics during FDA inspections. However, questions still arise around how to meet data integrity requirements when operating in the cloud. Regulatory requirements […]

In recent years, cloud technology has been embraced as an enabler of value creation, helping improve enterprise resilience, innovation speed and scalability without the need for large capital expenditures and even reducing ongoing operational costs. Fortune 500 pharma and MedTech companies could gain by 2030, $10-15 billion in improved EBITDA run rates and $25-30 billion […]

Like businesses in any other industry, pharmaceutical companies compete with each other. Despite their individual races to the finish line, the mission is the same: develop and produce lifesaving and life-changing treatments that move medicine, and humanity, forward. The recognition of this mutual goal, and the potential of breaking down siloes to share information, has […]

re:Invent is an opportunity to dive into innovative technologies and explore new ideas, and for healthcare and life sciences (HCLS) organizations, it is the time to think about how to reinvent collaborations, improve data driven decision making, and drive new discoveries, all with the goal of improving patient outcomes. At re:Invent 2022, we continued our […]

Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for pharmaceutical companies, so patients can get the critical medicines they need, faster. While patient safety has always been the highest priority, Merck & Co., Inc. (MSD), the leading global biopharmaceutical company, […]

Celebrating its 11th year, AWS re:Invent 2022 is gearing up to deliver a week of inspiring content, educational workshops and boot camps—all with plenty of peer-to-peer networking opportunities. This year’s conference will take place in Las Vegas, NV from November 28th through December 1st, and will have an engaging virtual component for those who cannot […]

Many Life Sciences organizations struggle with lab digitalization that can scale, automate data tasks, enable AI/ML, and create collaborative environments that support diverse R&D efforts. The AWS Digital Lab Strategy is a set of services, architectures, and partners to help take advantage of cloud scale and agility. Efforts to build digital lab capabilities seem to […]